Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Innoviva, Inc. | 150,000 | reported | 22 Oct 2013 | tx 2+165,000 |
| Theravance Biopharma, Inc. | 123,100 | reported | 03 Jun 2014 | tx 1+123,100 |
| Metacrine, Inc. | 16,500 | reported | 18 May 2022 | tx 3+66,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 May 2022 | GRANT_AWARD | Metacrine, Inc. | 16,500 | 0.00 USD | deriv |
| 24 May 2021 | GRANT_AWARD | Metacrine, Inc. | 16,500 | 0.00 USD | deriv |
| 17 Mar 2021 | GRANT_AWARD | Metacrine, Inc. | 33,000 | 0.00 USD | deriv |
| 03 Jun 2014 | GRANT_AWARD | Theravance Biopharma, Inc. | 123,100 | 0.00 USD | deriv |
| 22 Oct 2013 | GRANT_AWARD | Innoviva, Inc. | 15,000 | 0.00 USD | |
| 22 Oct 2013 | GRANT_AWARD | Innoviva, Inc. | 150,000 | 0.00 USD | deriv |